Join Hands to Build a Smarter India: Sign in | Join now
News

India Continues To Be Hub for Clinical Trials

By SiliconIndia  |   Monday, 27 May 2013, 03:11 Hrs   |    2 Comments
45
36
83
9
Print Email


The health secretary stressed the importance of clinical trials on humans, saying, "During the last 40 years, about 900 drug molecules of different therapeutic categories have been approved for marketing in India. Out of these 900, only seven drug molecules have been discovered and approved in India. Rest of them are discovered and developed in other countries like U.S., EU, Japan after going through complex process of research and drug development including clinical trial in human beings," as reported TNN.

However, in another instance, in a reply to an RTI, the office of drug controller general, ministry of family health and welfare, gave a list of deaths to the plaintiff during clinical trials. It revealed that 40 patients died from 2008 to 2011 during clinical trials in Rajasthan. Most of the patients in the state died during clinical trials, and were suffering from cancer, heart ailments and gastro related problems. It was noted that the state witnessed a huge number of deaths due to clinical trials.

But in a move to stop unethical clinical trials, the informed consent will soon have to be audio-visually recorded in order to safeguard the interests of patients in clinical trials. The move is to make sure that patients are not enlisted without sufficient information and counseling about the pros and cons of a drug trial.

Also Read: India's Drug Trials Industry Threatened Due To Slow Approvals
Also Read: India Ranks Second In Research among BRICK Nations



Experts on SiliconIndia
Sunil  Bhat
Project Management
HCL Infosystems Limi
Haresh  Motirale
Founder Director
Brandniti
Jeya  Padmanaban
President
JP Research, Inc.
Sonal  Rochani
President
Shakti Foundation
Chetan  Nagaonkar
Managing Director
eStomi Technologies
Deepak  Gupta
Business Analyst
Wipro Technologies
Sarvesh  Vaidya
Senior Director - HR
Tangoe
Aarthi  G R
HRM Specialist
PlasmaGen
Sign Up for DailyDose and Read the Day's Highlights
Write your comment now
 
Reader's comments(2)
1: These clinical trials should be in INDIA. Foreign drug companies should do these trials in their own countries and not use Indian ignorant people as guinea pigs as they have used other minorities in their own country in the past.
Posted by:rajkumar gupta - 29 Jul, 2013
2:
These trials should not be done in India.
rajkumar gupta Replied to: rajkumar gupta - 29 Jul, 2013
SPOTLIGHT
SiliconIndia About Us   |   Contact Us   |   Help   |   Community rules   |   Advertise with us   |   Sitemap   |  
News:       Technology   |   Enterprise   |   Gadgets   |   Startups   |   Finance   |   Business   |   Career   |   Magazine  |   Newsletter   |   News archive  
Cities:        CEO   |     Startup   |   Mobile   |   CIO   |   Women   |   BI   |   HR   |   SME   |   Cloud   |   Marketing   |   QA   |   Java   |   Web Developer  
Community:      Members   |   Blogs   |   Indian Entrepreneurs   |   Gyan   |   Advice   |   Community   |   Find   |   Events   |   CXO Insights  
Job Board:      Jobs   |   Freshers   |   Companies   |   HR Speak   |   Forum  
Online Courses:   Web Developer   |   Java Developer   |   CCNA Training   |   SEO   |   SAS   |   SQL Server 2005   |   J2EE
Education:   MBA   |   MCA   |   Engineering   |   Training Institute
Life:          Real Estate   |   Travel   |   Finance   |   Gadgets   |   Movie Reviews   |    Jokes  
Send your feedback and help us continue to improve SiliconIndia
© 2014 InfoConnect Web Technologies India Pvt Ltd. all rights reserved